Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets urged to vaccinate rabbits against RHD-2
RHD2 is a devastating disease that is highly fatal to unvaccinated rabbits.

British Rabbit Council shares its concerns

Vets are being urged to make rabbit hemorrhagic disease type 2 vaccine (RHD-2) part of their core rabbit vaccination programme.

In a letter to Vet Record (Vol 181 No 19), Sarah Elliott of the British Rabbit Council and Richard Saunders of the Rabbit Welfare Association
share their concerns that some vets are telling owners that vaccination is not required.

They write: ‘We have been concerned to hear that, following breeders recommending that newly acquired pet rabbits are taken to their vet for vaccination, some owners are being told that this is not necessary.

‘A recurring conversation at rabbit shows and on public social media has been that pet rabbit owners know nothing about RHD-2 despite having their rabbits vaccinated yearly against myxomatosis and RHD-1.

‘We would also ask that if a breeder approaches a vet to source and provide vaccine for them that you assist with this. Some breeders have a large number of rabbits and we would ask that you offer a site visit to vaccinate their stock.’

RHD2 is a devastating disease that is highly fatal to rabbits that have not been vaccinated. Since it's discovery in the UK in 2010, the disease has spread throughout much of the country and is now more dominant than RHD-1.

In October 2016, following concerns over a lack of vaccine, the European Medicines Agency issued a marketing authorisation for the vaccine ERAVAC to reduce mortality. This was later followed by Filavic, which received its UK licence in April 2017.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.